Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
FGFR3 2261 BAY-1163877 CHEMBL3545361 inhibitor ChemblInteractions
FGFR3 2261 AZD-4547 CHEMBL3184679 inhibitor TALC, MyCancerGenome, CKB, GuideToPharmacologyInteractions, ChemblInteractions 22869148, 26992226, 28108151, 22837387, 27550940, 26351323, 25589496, 27401245, 28034880
FGFR3 2261 INFIGRATINIB CHEMBL1852688 inhibitor TALC, CKB, GuideToPharmacologyInteractions, ChemblInteractions, CIViC, CancerCommons, MyCancerGenomeClinicalTrial 26270481, 28034880, 27053219, 22837387, 25294908, 25589496, 23002168, 27870574, 27401245, 27998968
FGFR3 2261 LY-2874455 CHEMBL3545264 inhibitor CKB, GuideToPharmacologyInteractions, ChemblInteractions 21900693, 28034880, 23175443
FGFR3 2261 BRIVANIB ALANINATE CHEMBL270995 inhibitor ChemblInteractions, TTD
FGFR3 2261 TRAFERMIN CHEMBL2108081 TdgClinicalTrial
FGFR3 2261 PD-173074 CHEMBL189584 CKB, CIViC 23558953, 21119661, 27998968, 22869148, 22837387, 25589496
FGFR3 2261 SORAFENIB CHEMBL1336 CKB 26270481
FGFR3 2261 ALPELISIB CHEMBL2396661 CKB
FGFR3 2261 ORANTINIB CHEMBL274654 inhibitor ChemblInteractions
FGFR3 2261 ENMD-2076 CHEMBL482968 inhibitor TALC, MyCancerGenome, ClearityFoundationClinicalTrial, ChemblInteractions
FGFR3 2261 JNJ-42756493 CHEMBL3545376 inhibitor OncoKB, CKB, GuideToPharmacologyInteractions, CIViC 26324363, 22837387, 26992226, 25609060, 28341788
FGFR3 2261 MK-2461 CHEMBL1822792 inhibitor GuideToPharmacologyInteractions
FGFR3 2261 PAZOPANIB CHEMBL477772 inhibitor CKB, DrugBank 23072642, 23558953
FGFR3 2261 ARQ-087 CHEMBL3545421 inhibitor TdgClinicalTrial, CKB, ChemblInteractions
FGFR3 2261 CP-459632 CHEMBL3545300 inhibitor ChemblInteractions
FGFR3 2261 CEDIRANIB CHEMBL491473 CKB 22238366, 25589496
FGFR3 2261 NINTEDANIB ESYLATE CHEMBL3039504 inhibitor ChemblInteractions
FGFR3 2261 PALIFERMIN CHEMBL1201821 TdgClinicalTrial, TEND, DrugBank 11149756, 7680555, 7890137, 11422746, 10821861
FGFR3 2261 PONATINIB CHEMBL1171837 inhibitor TALC, MyCancerGenome, CKB, DrugBank 23468082, 22238366, 28034880, 25294908
FGFR3 2261 XL-228 CHEMBL3545085 inhibitor TALC, MyCancerGenome
FGFR3 2261 AEE-788 CHEMBL587723 inhibitor TTD
FGFR3 2261 PAZOPANIB HYDROCHLORIDE CHEMBL1201733 inhibitor ChemblInteractions
FGFR3 2261 CHEMBL89363 CHEMBL89363 CKB, CIViC 21119661, 23175443, 23597562
FGFR3 2261 DACTOLISIB CHEMBL1879463 CKB 26270481
FGFR3 2261 AZD-5363 CHEMBL2178577 CKB 26351323
FGFR3 2261 XL-999 CHEMBL3545285 inhibitor ChemblInteractions, DrugBank
FGFR3 2261 DOVITINIB CHEMBL522892 inhibitor GuideToPharmacologyInteractions, TALC, CKB, ChemblInteractions, TTD, CancerCommons, ClearityFoundationClinicalTrial, MyCancerGenome, TdgClinicalTrial, CIViC 22238366, 28034880, 23175443, 24325461, 25589496, 27932416, 21119661
FGFR3 2261 MASITINIB CHEMBL1908391 inhibitor MyCancerGenome, ChemblInteractions, MyCancerGenomeClinicalTrial
FGFR3 2261 NINTEDANIB CHEMBL502835 inhibitor, Inhibitor TALC, GuideToPharmacologyInteractions, DrugBank, TdgClinicalTrial, ClearityFoundationClinicalTrial, MyCancerGenome, CKB 18559524, 22238366
FGFR3 2261 ENMD-981693 CHEMBL52885 inhibitor ChemblInteractions
FGFR3 2261 BRIVANIB CHEMBL377300 inhibitor CKB, ChemblInteractions 22238366
FGFR3 2261 BORTEZOMIB CHEMBL325041 CGI, DoCM 19331127, 21273588, 19381019, 25157968, 22869148, 26619011, 20542753
FGFR3 2261 CHEMBL35482 CHEMBL35482 CKB 14534538
FGFR3 2261 TRAMETINIB CHEMBL2103875 CKB 27338794
FGFR3 2261 SELUMETINIB CHEMBL1614701 CKB 26438159
FGFR3 2261 Ro-4987655 CHEMBL1614766 CKB 26438159
FGFR3 2261 BUPARLISIB CHEMBL2017974 CKB 28108151
FGFR3 2261 U-0126 CHEMBL100473 CKB 23298836

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID